Net Loss of Kabra Drugs reported to Rs 0.37 crore in the quarter ended March 2024 as against net loss of Rs 0.14 crore during the previous quarter ended March 2023. There were no Sales reported in the quarter ended March 2024 and during the previous quarter ended March 2023.For the full year,net loss reported to Rs 0.74 crore in the year ended March 2024 as against net loss of Rs 0.34 crore during the previous year ended March 2023. There were no Sales reported in the year ended March 2024 and during the previous year ended March 2023.Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2024.Powered by Capital Market - Live News

Net Loss of Kabra Drugs reported to Rs 0.11 crore in the quarter ended December 2023 as against net loss of Rs 0.06 crore during the previous quarter ended December 2022. There were no Sales reported in the quarter ended December 2023 and during the previous quarter ended December 2022.Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 17 February 2024 .Powered by Capital Market - Live News